Merck Animal Health firmly supports the responsible use of antibiotics to improve and maintain the health of animals. Antibiotics are life-saving veterinary products that treat bacterial infections in companion and food-producing animals. Their use in veterinary medicine also benefits humans by reducing the spread of disease between animals and humans; and helping facilitate a safe, efficient and sustainable food supply.
Our company is dedicated to the ethical and responsible treatment of all animals used in the development of medicines and vaccines. Decisions regarding animal care, use and welfare are made by balancing scientific knowledge and regulatory requirements with consideration of ethical and societal values.
Plasma-based products are used for both human and animal health and provide therapeutic benefits for a range of conditions. The safety and well-being of all animals is our first priority at Merck Animal Health. We only select partners that share these same values, and they are required to operate by the Merck Code of Conduct.
Zilmax Information Center
The benefits and safety of Zilmax® (zilpaterol hydrochloride) are well documented and the product has a 30+ year history of research and development and rigorous testing. Worldwide regulatory agencies have reviewed extensive data on Zilmax and have concluded that use of Zilmax, according to the label, is safe in cattle. It is important to understand these data included rigorous animal health safety and well-being studies – conducted by university experts – that found the behavior and movement of cattle fed Zilmax is normal.
Visit the Zilmax® Information Center here
Facts about Bravecto
Nothing is more important to Merck Animal Health than the safety and efficacy of our products and the health and well-being of animals, which is why it is so important that we share the facts about Bravecto® (fluralaner).
As new and evolving diseases and pathogens continue to endanger animal populations, Merck Animal Health, a leader in vaccine development, is at the forefront of bringing to market vaccine technology for optimal health of companion and food-producing animals through its SEQUIVITY™ Technology. The technology represents a revolutionary, flexible, rapid and targeted approach to the development of vaccines, using unique RNA Particles (RP), which are able to target a wide range of viruses and bacteria (pathogens).